Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (TCTR20250911002) titled 'The comparison of the efficacy of using a Intranasal decongestant combined with a intranasal corticosteroid versus double dose Intranasal corticosteroid in moderate to severe allergic rhinitis patient' on Sept. 11.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Bannawat Tantikun
Condition:
Allergic Rhinitis
Rhinitis, Allergic, Perennial
Quality of Life
Rhinitis, Allergic, Perennial
Quality of Life
Intervention:
Intranasal Fluticasone furoate 2 puffs each nostril once daily + Intranasal oxymetazoline 2 puffs each nostril twice daily,Intranasal Fluticasone furoate 2 puffs each nostril ...